PTX3 and coronary artery disorder: Pentraxin 3 (PTX3) emerges as a promising future biomarker for detecting vascular inflammation in coronary artery disease (CAD), offering greater specificity than hsCRP or IL-6 by localizing primarily to atherosclerotic lesions rather than reflecting systemic inflammation.